2019 AHA/ACC/HRS focused update of the 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society

Writing Group Members, Craig T January, L Samuel Wann, Hugh Calkins, Lin Y Chen, Joaquin E Cigarroa, Joseph C Cleveland Jr, Patrick T Ellinor, Michael D Ezekowitz, Michael E Field, Karen L Furie, Paul A Heidenreich, Katherine T Murray, Julie B Shea, Cynthia M Tracy, Clyde W Yancy, Writing Group Members, Craig T January, L Samuel Wann, Hugh Calkins, Lin Y Chen, Joaquin E Cigarroa, Joseph C Cleveland Jr, Patrick T Ellinor, Michael D Ezekowitz, Michael E Field, Karen L Furie, Paul A Heidenreich, Katherine T Murray, Julie B Shea, Cynthia M Tracy, Clyde W Yancy

No abstract available

Keywords: ACC/AHA Clinical Practice Guidelines; Acute coronary syndrome; Anticoagulants; Anticoagulation agents; Antiplatelet agents; Apixaban; Atrial fibrillation; Atrial flutter; Cardioversion; Coronary artery disease; Coronary heart disease; Dabigatran; Edoxaban; Focused update; Hypertension; Idarucizumab; Myocardial infarction; Obesity; Percutaneous coronary intervention; Risk factors; Rivaroxaban; Sleep apnea; Stents; Stroke; Thromboembolism; Warfarin.